Green tea polyphenols as a natural tumour cell proteasome inhibitor
Authors:
- 26 September 2008
- journal article
- review article
- Published by Springer Nature in Inflammopharmacology
- Vol. 16 (5) , 208-212
Abstract
The cancer-preventive effects of green tea and its main constituent (-)-epigallocatechin gallate [(-)-EGCG] are widely supported by results from epidemiological, cell culture, animal and clinical studies although the molecular target has not been well defined. We previously reported that ester bond-containing tea polyphenols, e. g. (-)-EGCG, and their synthetic analogs potently and specifically inhibited the proteasomal activity. Subsequently, we further demonstrated that methylation on green tea polyphenols under physiological conditions decreased their proteasome-inhibitory activity, contributing to decreased cancer-preventive effects of tea consumption. Since (-)-EGCG is unstable under physiological conditions, we also developed the peracetate-protected or prodrug form of (-)-EGCG, Pro-EGCG (1), and shown that Pro-EGCG (1) increases the bioavailability, stability, and proteasome-inhibitory and anticancer activities of (-)-EGCG in human breast cancer cells and xenografts, suggesting its potential use for cancer prevention and treatment.Keywords
This publication has 30 references indexed in Scilit:
- Methylation suppresses the proteasome‐inhibitory function of green tea polyphenolsJournal of Cellular Physiology, 2007
- A Novel Prodrug of the Green Tea Polyphenol (−)-Epigallocatechin-3-Gallate as a Potential Anticancer AgentCancer Research, 2007
- United States Food and Drug Administration Approval Summary: Bortezomib for the Treatment of Progressive Multiple Myeloma after One Prior TherapyClinical Cancer Research, 2006
- Perspectives for combination therapy to overcome drug-resistant multiple myelomaDrug Resistance Updates, 2005
- Bortezomib or High-Dose Dexamethasone for Relapsed Multiple MyelomaNew England Journal of Medicine, 2005
- Phase II Study of Proteasome Inhibitor Bortezomib in Relapsed or Refractory B-Cell Non-Hodgkin's LymphomaJournal of Clinical Oncology, 2005
- Ubiquitin-mediated proteolysis: biological regulation via destructionBioEssays, 2000
- Mechanistic Aspects of Green Tea as a Cancer Preventive: Effect of Components on Human Stomach Cancer Cell LinesJapanese Journal of Cancer Research, 1999
- Telomerase Inhibition, Telomere Shortening, and Senescence of Cancer Cells by Tea CatechinsBiochemical and Biophysical Research Communications, 1998
- Role of the Ubiquitin-Proteasome Pathway in Regulating Abundance of the Cyclin-Dependent Kinase Inhibitor p27Science, 1995